Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink
Background and purpose: Complex surgery and radiotherapy are the central pillars of loco-regional oncology treatment. This paper describes the reimbursement schemes used in radiation and complex surgical oncology, reports on literature and policy reviews. Material and methods: A systematic review of...
| Autores: | , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/186528 |
| Acceso en línea: | https://hdl.handle.net/2445/186528 |
| Access Level: | acceso abierto |
| Palabra clave: | Radioteràpia Cirurgia oncològica Càncer Tumors Radiotherapy Surgical oncology Cancer |
| id |
ES_331dfdb969c63db3e60d22a82f9d4bfa |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/186528 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethinkBorràs Andrés, Josep MariaCorral, JulietaAggarwal, AjayAudisio, RiccardoEspinàs Piñol, Josep AlfonsFigueras, JosepNaredi, PeterPanteli, DimitraPourel, NicolasPrades, JoanLievens, YolandeRadioteràpiaCirurgia oncològicaCàncerTumorsRadiotherapySurgical oncologyCancerTumorsBackground and purpose: Complex surgery and radiotherapy are the central pillars of loco-regional oncology treatment. This paper describes the reimbursement schemes used in radiation and complex surgical oncology, reports on literature and policy reviews. Material and methods: A systematic review of the literature of the reimbursement models has been carried out separately for radiotherapy and complex cancer surgery based on PRISMA guidelines. Using searches of PubMed and grey literature, we identified articles from scientific journals and reports published since 2000 on provider payment or reimbursement systems currently used in radiation oncology and complex cancer surgery, also including policy models. Results Most European health systems reimburse radiotherapy using a budget-based, fee-for-service or fraction-based system; while few reimburse services according to an episode-based model. Also, the reimbursement models for cancer surgery are mostly restricted to differences embedded in the DRG system and adjustments applied to the fees, based on the complexity of each surgical procedure. There is an enormous variability in reimbursement across countries, resulting in different incentives and different amounts paid for the same therapeutic strategy. Conclusion: A reimbursement policy, based on the episode of care as the basic payment unit, is advocated for. Innovation should be tackled in a two-tier approach: one defining the common criteria for reimbursement of proven evidence-based interventions; another for financing emerging innovation with uncertain definitive value. Relevant clinical and economic data, also collected real-life, should support reimbursement systems that mirror the actual cost of evidence-based practice.Elsevier2022info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/186528Articles publicats en revistes (Ciències Clíniques)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1016/j.ejso.2021.08.018European Journal of Surgical Oncology, 2022, vol. 48, num. 5, p. 967-977https://doi.org/10.1016/j.ejso.2021.08.018cc-by-nc-nd (c) Borràs, Josep M. et al., 2022https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1865282026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| title |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| spellingShingle |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink Borràs Andrés, Josep Maria Radioteràpia Cirurgia oncològica Càncer Tumors Radiotherapy Surgical oncology Cancer Tumors |
| title_short |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| title_full |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| title_fullStr |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| title_full_unstemmed |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| title_sort |
Innovation, value and reimbursement in radiation and complex surgical oncology: time to rethink |
| dc.creator.none.fl_str_mv |
Borràs Andrés, Josep Maria Corral, Julieta Aggarwal, Ajay Audisio, Riccardo Espinàs Piñol, Josep Alfons Figueras, Josep Naredi, Peter Panteli, Dimitra Pourel, Nicolas Prades, Joan Lievens, Yolande |
| author |
Borràs Andrés, Josep Maria |
| author_facet |
Borràs Andrés, Josep Maria Corral, Julieta Aggarwal, Ajay Audisio, Riccardo Espinàs Piñol, Josep Alfons Figueras, Josep Naredi, Peter Panteli, Dimitra Pourel, Nicolas Prades, Joan Lievens, Yolande |
| author_role |
author |
| author2 |
Corral, Julieta Aggarwal, Ajay Audisio, Riccardo Espinàs Piñol, Josep Alfons Figueras, Josep Naredi, Peter Panteli, Dimitra Pourel, Nicolas Prades, Joan Lievens, Yolande |
| author2_role |
author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
Radioteràpia Cirurgia oncològica Càncer Tumors Radiotherapy Surgical oncology Cancer Tumors |
| topic |
Radioteràpia Cirurgia oncològica Càncer Tumors Radiotherapy Surgical oncology Cancer Tumors |
| description |
Background and purpose: Complex surgery and radiotherapy are the central pillars of loco-regional oncology treatment. This paper describes the reimbursement schemes used in radiation and complex surgical oncology, reports on literature and policy reviews. Material and methods: A systematic review of the literature of the reimbursement models has been carried out separately for radiotherapy and complex cancer surgery based on PRISMA guidelines. Using searches of PubMed and grey literature, we identified articles from scientific journals and reports published since 2000 on provider payment or reimbursement systems currently used in radiation oncology and complex cancer surgery, also including policy models. Results Most European health systems reimburse radiotherapy using a budget-based, fee-for-service or fraction-based system; while few reimburse services according to an episode-based model. Also, the reimbursement models for cancer surgery are mostly restricted to differences embedded in the DRG system and adjustments applied to the fees, based on the complexity of each surgical procedure. There is an enormous variability in reimbursement across countries, resulting in different incentives and different amounts paid for the same therapeutic strategy. Conclusion: A reimbursement policy, based on the episode of care as the basic payment unit, is advocated for. Innovation should be tackled in a two-tier approach: one defining the common criteria for reimbursement of proven evidence-based interventions; another for financing emerging innovation with uncertain definitive value. Relevant clinical and economic data, also collected real-life, should support reimbursement systems that mirror the actual cost of evidence-based practice. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/186528 |
| url |
https://hdl.handle.net/2445/186528 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1016/j.ejso.2021.08.018 European Journal of Surgical Oncology, 2022, vol. 48, num. 5, p. 967-977 https://doi.org/10.1016/j.ejso.2021.08.018 |
| dc.rights.none.fl_str_mv |
cc-by-nc-nd (c) Borràs, Josep M. et al., 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by-nc-nd (c) Borràs, Josep M. et al., 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Ciències Clíniques) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869405725939204096 |
| score |
15,300719 |